HRP20050183A2 - Preparation of 1h-imidazo [4,5-c]quinolin-4-aminesvia novel 1h-imidazo [4,5-c]quinolin-4-cyano and 1h-imidazo [4,5-c]quinolin-4-carboxamide intermediates - Google Patents

Preparation of 1h-imidazo [4,5-c]quinolin-4-aminesvia novel 1h-imidazo [4,5-c]quinolin-4-cyano and 1h-imidazo [4,5-c]quinolin-4-carboxamide intermediates

Info

Publication number
HRP20050183A2
HRP20050183A2 HR20050183A HRP20050183A HRP20050183A2 HR P20050183 A2 HRP20050183 A2 HR P20050183A2 HR 20050183 A HR20050183 A HR 20050183A HR P20050183 A HRP20050183 A HR P20050183A HR P20050183 A2 HRP20050183 A2 HR P20050183A2
Authority
HR
Croatia
Prior art keywords
imidazo
quinolin
cyano
quinoline
preparation
Prior art date
Application number
HR20050183A
Other languages
English (en)
Inventor
Merli Valeriano
Mantovani Silvia
Bianchi Stefano
Original Assignee
Teva Gy�gyszergy�r R�szv�nyt�rsas�g
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Gy�gyszergy�r R�szv�nyt�rsas�g filed Critical Teva Gy�gyszergy�r R�szv�nyt�rsas�g
Publication of HRP20050183A2 publication Critical patent/HRP20050183A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
HR20050183A 2002-07-26 2003-07-28 Preparation of 1h-imidazo [4,5-c]quinolin-4-aminesvia novel 1h-imidazo [4,5-c]quinolin-4-cyano and 1h-imidazo [4,5-c]quinolin-4-carboxamide intermediates HRP20050183A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39859202P 2002-07-26 2002-07-26
PCT/US2003/023543 WO2004011462A1 (en) 2002-07-26 2003-07-28 Preparation of 1h-imidazo [4,5-c] quinolin-4-amines via novel 1h-imidazo [4,5-c] quinolin-4-cyano and 1h-imidazo [4,5-c] quinolin-4-carboxamide intermediates

Publications (1)

Publication Number Publication Date
HRP20050183A2 true HRP20050183A2 (en) 2005-06-30

Family

ID=31188428

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050183A HRP20050183A2 (en) 2002-07-26 2003-07-28 Preparation of 1h-imidazo [4,5-c]quinolin-4-aminesvia novel 1h-imidazo [4,5-c]quinolin-4-cyano and 1h-imidazo [4,5-c]quinolin-4-carboxamide intermediates

Country Status (18)

Country Link
US (3) US6841678B2 (de)
EP (1) EP1539752B1 (de)
JP (1) JP2005537287A (de)
KR (1) KR20050030958A (de)
CN (1) CN100372847C (de)
AT (1) ATE357445T1 (de)
AU (1) AU2003254221A1 (de)
CA (1) CA2493158A1 (de)
DE (1) DE60312701T8 (de)
DK (1) DK1539752T3 (de)
ES (1) ES2282691T3 (de)
HR (1) HRP20050183A2 (de)
IL (2) IL166307A0 (de)
MX (1) MXPA05000997A (de)
PL (1) PL374866A1 (de)
PT (1) PT1539752E (de)
SI (1) SI1539752T1 (de)
WO (1) WO2004011462A1 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6677347B2 (en) * 2000-12-08 2004-01-13 3M Innovative Properties Company Sulfonamido ether substituted imidazoquinolines
US6688134B2 (en) * 2001-11-13 2004-02-10 John C. Barton Touchless automatic fiber optic beverage/ice dispenser
CN1674894A (zh) 2002-06-07 2005-09-28 3M创新有限公司 醚取代的咪唑并吡啶
ATE357445T1 (de) * 2002-07-26 2007-04-15 Teva Gyogyszergyar Zartkoeruee Darstellung von 1h-imidazo(4,5-c)chinolin-4- aminen über neue 1h-imidazo(4,5-c)chinolin-4- cyano- und 1h-imidazo(4,5-c)chinolin-4-carboxamid intermediate
US20040265351A1 (en) 2003-04-10 2004-12-30 Miller Richard L. Methods and compositions for enhancing immune response
WO2004096144A2 (en) * 2003-04-28 2004-11-11 3M Innovative Properties Company Compositions and methods for induction of opioid receptors
AR045260A1 (es) * 2003-08-12 2005-10-19 3M Innovative Properties Co Compuestos que contienen imidazo-oxima sustituidos
AU2004266657B2 (en) * 2003-08-14 2009-07-02 3M Innovative Properties Company Lipid-modified immune response modifiers
AU2004268625B2 (en) * 2003-08-27 2011-03-31 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
CA2537763A1 (en) * 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
EP1673087B1 (de) 2003-10-03 2015-05-13 3M Innovative Properties Company Alkoxy-substituierte imidazochinoline
US7544697B2 (en) * 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
AR046172A1 (es) 2003-10-03 2005-11-30 3M Innovative Properties Co Pirazolopiridinas y sus analogos; composiciones farmaceuticas que los contienen y su uso en la inhibicion de la biosintesis de citocinas
US20090075980A1 (en) * 2003-10-03 2009-03-19 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and Analogs Thereof
JP2007511535A (ja) 2003-11-14 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー ヒドロキシルアミン置換イミダゾ環化合物
CA2545774A1 (en) * 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
US8778963B2 (en) * 2003-11-25 2014-07-15 3M Innovative Properties Company Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
EP1687307B1 (de) * 2003-11-25 2016-01-06 3M Innovative Properties Company Substituierte imidazoringsysteme und verfahren
WO2005076783A2 (en) * 2003-12-04 2005-08-25 3M Innovative Properties Company Sulfone substituted imidazo ring ethers
WO2005066170A1 (en) * 2003-12-29 2005-07-21 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
AU2004312510A1 (en) * 2003-12-29 2005-07-21 3M Innovative Properties Company Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds
CA2551399A1 (en) * 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
US8697873B2 (en) * 2004-03-24 2014-04-15 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US20080015184A1 (en) * 2004-06-14 2008-01-17 3M Innovative Properties Company Urea Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthyridines
WO2005123080A2 (en) * 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7897609B2 (en) * 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006009826A1 (en) * 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
EP1765348B1 (de) * 2004-06-18 2016-08-03 3M Innovative Properties Company Substituierte imidazochinoline, imidazopyridine sowie imidazonaphthyridine
US7915281B2 (en) * 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
US8541438B2 (en) 2004-06-18 2013-09-24 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
JP2008511683A (ja) 2004-09-02 2008-04-17 スリーエム イノベイティブ プロパティズ カンパニー 2−アミノ1h−イミダゾ環構造および方法
WO2006026760A2 (en) * 2004-09-02 2006-03-09 3M Innovative Properties Company 1-amino imidazo-containing compounds and methods
WO2006028962A2 (en) * 2004-09-02 2006-03-16 3M Innovative Properties Company 1-alkoxy 1h-imidazo ring systems and methods
JP2008515928A (ja) * 2004-10-08 2008-05-15 スリーエム イノベイティブ プロパティズ カンパニー Dnaワクチンのためのアジュバント
WO2006063072A2 (en) * 2004-12-08 2006-06-15 3M Innovative Properties Company Immunomodulatory compositions, combinations and methods
US8436176B2 (en) * 2004-12-30 2013-05-07 Medicis Pharmaceutical Corporation Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
SI1830876T1 (sl) * 2004-12-30 2015-08-31 Meda Ab Uporaba imikvimoda za zdravljenje kožnih metastaz, ki izhajajo iz rakavega tumorja dojke
AU2005326708C1 (en) 2004-12-30 2012-08-30 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
EP1831226B1 (de) * 2004-12-30 2012-08-08 3M Innovative Properties Company Chirale tetracyklische verbindungen, die interferon biosyntheze induzieren
WO2006073939A2 (en) * 2004-12-30 2006-07-13 Takeda Pharmaceutical Company Limited 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine methanesulfonate
WO2006084251A2 (en) * 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
AU2006338521A1 (en) 2005-02-09 2007-10-11 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods
WO2006086449A2 (en) 2005-02-09 2006-08-17 Coley Pharmaceutical Group, Inc. Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
AU2006216997A1 (en) * 2005-02-11 2006-08-31 Coley Pharmaceutical Group, Inc. Substituted imidazoquinolines and imidazonaphthyridines
WO2006086634A2 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
CA2598695A1 (en) * 2005-02-23 2006-09-21 Coley Pharmaceutical Group, Inc. Hydroxyalkyl substituted imidazoquinolines
WO2006091647A2 (en) * 2005-02-23 2006-08-31 Coley Pharmaceutical Group, Inc. Method of preferentially inducing the biosynthesis of interferon
AU2006216799A1 (en) 2005-02-23 2006-08-31 Coley Pharmaceutical Group, Inc. Hydroxyalkyl substituted imidazonaphthyridines
WO2006091567A2 (en) * 2005-02-23 2006-08-31 Coley Pharmaceutical Group, Inc. Hydroxyalkyl substituted imidazoquinoline compounds and methods
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
EP1863814A1 (de) 2005-04-01 2007-12-12 Coley Pharmaceutical Group, Inc. 1-substitutierte pyrazolo-(3,4-c)-ringverbindungen als cytokinbiosynthese-modulatoren für die behandlung viraler infektionen und neoplastischer erkrankungen
WO2006116475A2 (en) * 2005-04-25 2006-11-02 3M Innovative Properties Company Immunostimulatory compositions
ZA200803029B (en) * 2005-09-09 2009-02-25 Coley Pharm Group Inc Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
AU2006287270A1 (en) * 2005-09-09 2007-03-15 Coley Pharmaceutical Group, Inc. Amide and carbamate derivatives of N-{2-[4-amino-2- (ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide and methods
US8088790B2 (en) * 2005-11-04 2012-01-03 3M Innovative Properties Company Hydroxy and alkoxy substituted 1H-imidazoquinolines and methods
EP1988896A4 (de) 2006-02-22 2011-07-27 3M Innovative Properties Co Konjugate zur modifizierung von immunreaktionen
US8329721B2 (en) * 2006-03-15 2012-12-11 3M Innovative Properties Company Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods
US7906506B2 (en) * 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
US8178539B2 (en) * 2006-09-06 2012-05-15 3M Innovative Properties Company Substituted 3,4,6,7-tetrahydro-5H-1,2a,4a,8-tetraazacyclopenta[cd]phenalenes and methods
US20080149123A1 (en) 2006-12-22 2008-06-26 Mckay William D Particulate material dispensing hairbrush with combination bristles
CA2808624C (en) 2010-08-17 2019-05-14 3M Innovative Properties Company Lipidated immune response modifier compound compositions, formulations, and methods
US9107958B2 (en) 2011-06-03 2015-08-18 3M Innovative Properties Company Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom
WO2012167088A1 (en) 2011-06-03 2012-12-06 3M Innovative Properties Company Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
CN104725304B (zh) * 2013-12-18 2017-08-18 上海医药工业研究院 一种3‑取代‑2‑氰基吡啶类化合物的制备方法
WO2019123178A1 (en) 2017-12-20 2019-06-27 3M Innovative Properties Company Amide substitued imidazo[4,5-c]quinoline compounds with a branched chain linking group for use as an immune response modifier
FR3113287B1 (fr) 2020-08-07 2023-06-23 Phv Pharma Procédé industriel de synthèse de l’imiquimod à partir de la quinolèine-2,4-diol applicable à son utilisation pharmaceutique

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73534A (en) 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
ZA848968B (en) 1983-11-18 1986-06-25 Riker Laboratories Inc 1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines
CA1271477A (en) 1983-11-18 1990-07-10 John F. Gerster 1h-imidazo[4,5-c]quinolin-4-amines
US4689388A (en) 1985-01-24 1987-08-25 Ajinomoto Co., Inc. One pack type alicyclic epoxy resin compositions
US5238944A (en) 1988-12-15 1993-08-24 Riker Laboratories, Inc. Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
DK0385630T3 (da) 1989-02-27 1997-05-12 Riker Laboratories Inc 1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler
US5756747A (en) 1989-02-27 1998-05-26 Riker Laboratories, Inc. 1H-imidazo 4,5-c!quinolin-4-amines
US4988815A (en) 1989-10-26 1991-01-29 Riker Laboratories, Inc. 3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
ES2071340T3 (es) * 1990-10-05 1995-06-16 Minnesota Mining & Mfg Procedimiento para la preparacion de imidazo(4,5-c)quinolin-4-aminas.
JP2941413B2 (ja) 1990-11-28 1999-08-25 ライカー ラボラトリース インコーポレーテッド 1H―イミダゾ[4,5―c]キノリン類の製造方法
US5175296A (en) 1991-03-01 1992-12-29 Minnesota Mining And Manufacturing Company Imidazo[4,5-c]quinolin-4-amines and processes for their preparation
US5395937A (en) 1993-01-29 1995-03-07 Minnesota Mining And Manufacturing Company Process for preparing quinoline amines
JP3257893B2 (ja) * 1993-10-18 2002-02-18 三菱電機株式会社 位相シフトマスク、その位相シフトマスクの製造方法およびその位相シフトマスクを用いた露光方法
US5741908A (en) 1996-06-21 1998-04-21 Minnesota Mining And Manufacturing Company Process for reparing imidazoquinolinamines
HUP0204474A3 (en) * 2000-02-09 2004-07-28 Hokuriku Pharmaceutical 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
GB0211649D0 (en) * 2002-05-21 2002-07-03 Novartis Ag Organic compounds
ATE357445T1 (de) * 2002-07-26 2007-04-15 Teva Gyogyszergyar Zartkoeruee Darstellung von 1h-imidazo(4,5-c)chinolin-4- aminen über neue 1h-imidazo(4,5-c)chinolin-4- cyano- und 1h-imidazo(4,5-c)chinolin-4-carboxamid intermediate

Also Published As

Publication number Publication date
US20050101627A1 (en) 2005-05-12
CA2493158A1 (en) 2004-02-05
AU2003254221A1 (en) 2004-02-16
CN100372847C (zh) 2008-03-05
EP1539752A1 (de) 2005-06-15
DE60312701T2 (de) 2007-12-06
PT1539752E (pt) 2007-05-31
DK1539752T3 (da) 2007-07-16
MXPA05000997A (es) 2005-05-16
US7335772B2 (en) 2008-02-26
JP2005537287A (ja) 2005-12-08
IL166307A (en) 2010-04-15
US20050119294A1 (en) 2005-06-02
US7166721B2 (en) 2007-01-23
WO2004011462A1 (en) 2004-02-05
IL166307A0 (en) 2006-01-15
KR20050030958A (ko) 2005-03-31
DE60312701T8 (de) 2008-08-21
ATE357445T1 (de) 2007-04-15
SI1539752T1 (sl) 2007-08-31
US20040063743A1 (en) 2004-04-01
PL374866A1 (en) 2005-11-14
CN1684963A (zh) 2005-10-19
ES2282691T3 (es) 2007-10-16
DE60312701D1 (de) 2007-05-03
EP1539752B1 (de) 2007-03-21
US6841678B2 (en) 2005-01-11

Similar Documents

Publication Publication Date Title
HRP20050183A2 (en) Preparation of 1h-imidazo [4,5-c]quinolin-4-aminesvia novel 1h-imidazo [4,5-c]quinolin-4-cyano and 1h-imidazo [4,5-c]quinolin-4-carboxamide intermediates
PL374884A1 (en) Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via 1h-imidazo[4,5-c]quinolin-4-phthalimide intermediates
WO2008024415A8 (en) Process for the synthesis of cmhtp and intermediates thereof
WO2003101949A3 (en) Process for imidazo[4,5-c]pyridin-4-amines
WO2004110991A3 (en) PROCESS FOR IMIDAZO[4,5-c]PYRIDIN-4-AMINES
WO2005037198A3 (en) Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
WO2008021345A3 (en) Process for the synthesis of 9-hydroxy risperidone (paliperidone)
NO20076651L (no) Fremgangsmate for fremstilling av 2-metyl-l-(2-metylpropyl)-1H-imidazo[4,5-c] [1,5]naftyridin-4-amin
TW200736256A (en) Process for the preparation of substituted heterocycles
NO20082757L (no) Substituerte imidazoquinoliner, imidazonaftyridiner og imidazopyridiner, sammensetninger og fremgangsmater
IL152411A0 (en) Zolpidem hemitartrate
EP1467735A4 (de) Polymorphe von clopidogrel-hydrogensulfat
IL175009A0 (en) Ccr-2 antagonist salt
GEP20084492B (en) New 4-benzylidene-piperidin derivatives
PL372409A1 (en) Novel alkoxypyridine-derivatives
SI1534707T1 (sl) Substituirani derivati 2,4-dihidro-pirolo(3,4-b)kinolin-9-ona, uporabni kot fosfodiesterazni inhibitorji
WO2008140646A3 (en) Process for the synthesis of cmhtp and intermediates thereof
ZA200704709B (en) A process for the preparation of substantially pure 4-mino-1-isobutyl-1H-imidazo[4,5-c]-quinoline (imiquimod)
HUP0103912A3 (en) Substituted alkylpyridazinone derivatives, process for their preparation, their use for the preparation of pharmaceutical compositions with anxiolytic activity
WO2009130710A3 (en) A process for the preparation of paliperidone intermediates
HUP0104873A3 (en) Refined process for the preparation of 3-{2-[4-(6-fluoro-1,2-benzizoxazol-3-yl)-1-piperidinyl]-ethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one
ATE394398T1 (de) Verfahren zur herstellung von imidazo(1,2- a)pyridin-3-acetamiden
AU2003248987A1 (en) Process for preparing 7-azaindoles
HUP0401991A3 (en) Method for producing of substituted imidazo[1,2-a]-5,6,7,8-tetrahydropyridine-8-on derivatives
IL174189A0 (en) Process for preparing 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: TEVA GYOGYSZERGYAR ZARTKOERUEN MUKOEDO RESZVENYTAR

ODRP Renewal fee for the maintenance of a patent

Payment date: 20070703

Year of fee payment: 5

OBST Application withdrawn